Silberbauer, Leo R. http://orcid.org/0000-0002-8521-1012
Rischka, Lucas
Vraka, Chrysoula
Hartmann, Annette M.
Godbersen, Godber Mathis http://orcid.org/0000-0002-9739-0724
Philippe, Cécile
Pacher, Daniel
Nics, Lukas
Klöbl, Manfred http://orcid.org/0000-0003-2107-8803
Unterholzner, Jakob http://orcid.org/0000-0001-9274-6990
Stimpfl, Thomas
Wadsak, Wolfgang http://orcid.org/0000-0003-4479-8053
Hahn, Andreas http://orcid.org/0000-0001-9727-7580
Hacker, Marcus
Rujescu, Dan http://orcid.org/0000-0002-1432-313X
Kasper, Siegfried http://orcid.org/0000-0001-8278-191X
Lanzenberger, Rupert http://orcid.org/0000-0003-4641-9539
Gryglewski, Gregor http://orcid.org/0000-0002-7344-8071
Funding for this research was provided by:
Austrian Science Fund (KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504, KLI 504)
Else Kröner-Fresenius-Stiftung (2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192, 2014_A192)
Österreichischen Akademie der Wissenschaften
Article History
Received: 7 November 2021
Revised: 20 July 2022
Accepted: 29 July 2022
First Online: 7 September 2022
Competing interests
: RL received travel grants and/or conference speaker honoraria from Bruker BioSpin within the last three years and investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. SK received grants/ research support, consulting fees and/or honoraria within the last three years. He received grant/research support from Lundbeck; he has served as a consultant or on advisory boards for Celegne, IQVIA, Janssen, Lundbeck, Mundipharma, Recordati, Takeda and Schwabe; and he has served on speaker bureaus for Angelini, Aspen Farmaceutica S.A., Janssen, Krka Pharma, Lundbeck, Medichem Pharmaceuticals Inc., Neuraxpharma, OM Pharma, Pierre Fabre, Sanofi, Servier, Schwabe, Sun Pharma. Without relevance to this work, WW is a part-time employee of CBmed GmbH, Graz, Austria and a co-founder/co-owner of MINUTE medical GmbH, Vienna, Austria. Within the last years, he received research grants from ITM, Garching, Germany, and Scintomics, Fürstenfeldbruck, Germany. The remaining authors declare no potential conflict of interest with respect to the research, authorship, and/ or publication of this article.